LBIO (Longevity Biomedical) Quick Ratio: 0.00 (As of . 20)


What is Longevity Biomedical Quick Ratio?

Longevity Biomedical LBIO Quick Ratio is 0.00 as of . 20.

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Longevity Biomedical's quick ratio for the quarter that ended in . 20 was 0.00.

Longevity Biomedical has a quick ratio of 0.00. It indicates that the company cannot currently fully pay back its current liabilities.

The historical rank and industry rank for Longevity Biomedical's Quick Ratio or its related term are showing as below:

LBIO's Quick Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 3.6
* Ranked among companies with meaningful Quick Ratio only.

Longevity Biomedical  (NAS:LBIO) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.

Longevity Biomedical Quick Ratio Related Terms

Longevity Biomedical Quick Ratio Historical Data

* Premium members only.

The historical data trend for Longevity Biomedical's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Longevity Biomedical Quick Ratio Chart

Longevity Biomedical Annual Data
Trend
Quick Ratio

Longevity Biomedical Semi-Annual Data
Quick Ratio

LBIO vs : Quick Ratio Comparison

For the Biotechnology subindustry, Longevity Biomedical's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Longevity Biomedical Quick Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Longevity Biomedical's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Longevity Biomedical's Quick Ratio falls into.


Longevity Biomedical Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Longevity Biomedical's Quick Ratio for the fiscal year that ended in . 20 is calculated as

Quick Ratio (A: . 20 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(-)/
=

Longevity Biomedical's Quick Ratio for the quarter that ended in . 20 is calculated as

Quick Ratio (Q: . 20 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(-)/
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Quick Ratio →
What does a Quick Ratio of 0.00 mean?
Longevity Biomedical (LBIO) has a Quick Ratio of 0.00 as of . 20. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Longevity Biomedical and its competitors.
Is Longevity Biomedical's Quick Ratio too high?
Longevity Biomedical's current Quick Ratio is 0.00.
How does Longevity Biomedical's Quick Ratio compare to ?
Longevity Biomedical's Quick Ratio of 0.00 can be compared against companies in the Biotechnology industry. The industry median Quick Ratio is 3.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.60, based on 1,412 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Longevity Biomedical and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Longevity Biomedical's current Quick Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Longevity Biomedical stock overvalued right now?
Longevity Biomedical (LBIO) has a current Quick Ratio of 0.00. The current Quick Ratio is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Longevity Biomedical (LBIO), the current Quick Ratio is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Longevity Biomedical Business Description

Comparable Companies
Address 12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011
Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.